
Robert S. Landsman
Examiner (ID: 14280, Phone: (571)272-0888 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1647, 1646 |
| Total Applications | 2029 |
| Issued Applications | 1242 |
| Pending Applications | 272 |
| Abandoned Applications | 566 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8586141
[patent_doc_number] => 20130004961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'METHODS OF DETECTING A SWEET-SENSITIVE CELL'
[patent_app_type] => utility
[patent_app_number] => 13/477907
[patent_app_country] => US
[patent_app_date] => 2012-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 29901
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13477907
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/477907 | Methods of screening T1R1/T1R3 heteromeric receptors for compounds that modulate umami taste signaling | May 21, 2012 | Issued |
Array
(
[id] => 8995000
[patent_doc_number] => 08518884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha inhibitor'
[patent_app_type] => utility
[patent_app_number] => 13/476412
[patent_app_country] => US
[patent_app_date] => 2012-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 36
[patent_no_of_words] => 25722
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13476412
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/476412 | Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha inhibitor | May 20, 2012 | Issued |
Array
(
[id] => 8495461
[patent_doc_number] => 20120294869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'Methods for Treating Fatty Liver Disease'
[patent_app_type] => utility
[patent_app_number] => 13/471853
[patent_app_country] => US
[patent_app_date] => 2012-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15116
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13471853
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/471853 | Methods for Treating Fatty Liver Disease | May 14, 2012 | Abandoned |
Array
(
[id] => 8370580
[patent_doc_number] => 20120219968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'GPCR Expressing Cell Lines and Antibodies'
[patent_app_type] => utility
[patent_app_number] => 13/470665
[patent_app_country] => US
[patent_app_date] => 2012-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 25995
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470665
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/470665 | GPCR Expressing Cell Lines and Antibodies | May 13, 2012 | Abandoned |
Array
(
[id] => 10568464
[patent_doc_number] => 09291626
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-22
[patent_title] => 'Diagnosis and treatment of chronic obstructive pulmonary disease (COPD)'
[patent_app_type] => utility
[patent_app_number] => 14/117157
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 15324
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117157
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/117157 | Diagnosis and treatment of chronic obstructive pulmonary disease (COPD) | May 10, 2012 | Issued |
Array
(
[id] => 8515861
[patent_doc_number] => 20120315269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-13
[patent_title] => 'IMMUNOGLOBULIN-LIKE TRANSCRIPT (ILT) RECEPTORS AS CD8 ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/465371
[patent_app_country] => US
[patent_app_date] => 2012-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 15797
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13465371
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/465371 | IMMUNOGLOBULIN-LIKE TRANSCRIPT (ILT) RECEPTORS AS CD8 ANTAGONISTS | May 6, 2012 | Abandoned |
Array
(
[id] => 9523586
[patent_doc_number] => 08747845
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-10
[patent_title] => 'Methods of treatment by administering antibodies that bind colony stimulating factor 1 receptor (CSF1R)'
[patent_app_type] => utility
[patent_app_number] => 13/464503
[patent_app_country] => US
[patent_app_date] => 2012-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 24917
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13464503
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/464503 | Methods of treatment by administering antibodies that bind colony stimulating factor 1 receptor (CSF1R) | May 3, 2012 | Issued |
Array
(
[id] => 10595554
[patent_doc_number] => 09316639
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-19
[patent_title] => 'Use of gelsolin to diagnose and treat inflammatory diseases'
[patent_app_type] => utility
[patent_app_number] => 13/455878
[patent_app_country] => US
[patent_app_date] => 2012-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 16600
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13455878
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/455878 | Use of gelsolin to diagnose and treat inflammatory diseases | Apr 24, 2012 | Issued |
Array
(
[id] => 8515871
[patent_doc_number] => 20120315280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-13
[patent_title] => 'ANTIBODY THERAPY FOR USE IN THE DIGESTIVE TRACT'
[patent_app_type] => utility
[patent_app_number] => 13/452026
[patent_app_country] => US
[patent_app_date] => 2012-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18524
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13452026
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/452026 | Methods of treating mucositis using anti-TNF antibodies | Apr 19, 2012 | Issued |
Array
(
[id] => 8441494
[patent_doc_number] => 20120258110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'FDF03 ANTIBODIES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/446754
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10379
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13446754
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/446754 | FDF03 ANTIBODIES AND USES THEREOF | Apr 12, 2012 | Abandoned |
Array
(
[id] => 8866012
[patent_doc_number] => 20130149715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'G-PROTEIN-CONJUGATED RECEPTOR HAVING ALTERED LIGAND AFFINITY, AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/445358
[patent_app_country] => US
[patent_app_date] => 2012-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8800
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13445358
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/445358 | G-PROTEIN-CONJUGATED RECEPTOR HAVING ALTERED LIGAND AFFINITY, AND USE THEREOF | Apr 11, 2012 | Abandoned |
Array
(
[id] => 8393153
[patent_doc_number] => 20120230993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'AXL TYROSINE KINASE INHIBITORS AND METHODS OF MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/439176
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19434
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13439176
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/439176 | Methods of treating cancer by administering an Axl ligand-binding portion of an Axl tyrosine kinase receptor extracellular domain | Apr 3, 2012 | Issued |
Array
(
[id] => 9698606
[patent_doc_number] => 20140248291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-04
[patent_title] => 'Modulation of Cellular Migration'
[patent_app_type] => utility
[patent_app_number] => 14/008979
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 24208
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008979
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/008979 | Modulation of Cellular Migration | Mar 29, 2012 | Abandoned |
Array
(
[id] => 9140475
[patent_doc_number] => 08580937
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-12
[patent_title] => 'cDNA-derived nucleic acids encoding red-shifted channelrhodopsins'
[patent_app_type] => utility
[patent_app_number] => 13/420352
[patent_app_country] => US
[patent_app_date] => 2012-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 32795
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13420352
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/420352 | cDNA-derived nucleic acids encoding red-shifted channelrhodopsins | Mar 13, 2012 | Issued |
Array
(
[id] => 9191025
[patent_doc_number] => 20130330340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'PRODUCTION OF N- AND O-SIALYLATED TNFRII-FC FUSION PROTEIN IN YEAST'
[patent_app_type] => utility
[patent_app_number] => 13/985130
[patent_app_country] => US
[patent_app_date] => 2012-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 31023
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13985130
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/985130 | PRODUCTION OF N- AND O-SIALYLATED TNFRII-FC FUSION PROTEIN IN YEAST | Feb 19, 2012 | Abandoned |
Array
(
[id] => 9042289
[patent_doc_number] => 20130244927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'POLYNUCLEOTIDES ENCODING SIGNAL PEPTIDE-CONTAINING MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 13/397592
[patent_app_country] => US
[patent_app_date] => 2012-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43989
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13397592
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/397592 | Compositions comprising signal peptide-containing proteins | Feb 14, 2012 | Issued |
Array
(
[id] => 10905263
[patent_doc_number] => 20140308276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'ANTI-OX40 ANTIBODIES AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/240535
[patent_app_country] => US
[patent_app_date] => 2012-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 29034
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14240535
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/240535 | Anti-OX40 antibodies and methods of treating cancer | Feb 8, 2012 | Issued |
Array
(
[id] => 8312614
[patent_doc_number] => 20120189633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'ANTI-KIT ANTIBODIES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/358210
[patent_app_country] => US
[patent_app_date] => 2012-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 85952
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13358210
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/358210 | ANTI-KIT ANTIBODIES AND USES THEREOF | Jan 24, 2012 | Abandoned |
Array
(
[id] => 9041616
[patent_doc_number] => 20130244254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'T1R HETERO-OLIGOMERIC TASTE RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 13/357110
[patent_app_country] => US
[patent_app_date] => 2012-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24545
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13357110
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/357110 | Methods of screening heteromeric T1R2/T1R3 receptors for compounds which modulate sweet taste signaling | Jan 23, 2012 | Issued |
Array
(
[id] => 9107239
[patent_doc_number] => 20130280371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'Compositions and Methods for Providing or Modulating Sweet Taste or Methods of Screening Therefor'
[patent_app_type] => utility
[patent_app_number] => 13/978462
[patent_app_country] => US
[patent_app_date] => 2012-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16898
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978462
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/978462 | Methods of identifying molecules that provide or enhance sweet taste | Jan 16, 2012 | Issued |